论文部分内容阅读
作者对1981年1月至1986年12月39例卵巢癌在细胞减灭术及化疗结束后,临床未查到肿瘤的病例在 Johannesburg 医院作为处理计划的一部分进行了二次探查术(2LL)。其中35例曾行细胞减灭术,Ⅱ、Ⅲ和Ⅳ期患者术后给予顺铂(cis-pla-tinum)、阿霉素(doxorubicin)和环磷酰胺(cyclophosphamide),简称(CAP)联合化疗,大多数Ⅰ期患者术后接受烷化剂单一治疗。2LL 前,进行多方面检查,包括各种肿瘤标记、EKG、胸部 X 光检查、静脉肾盂造影、钡餐和超声检查。2LL 包括:为细胞学检查收集腹腔冲
The authors undertook a second exploration (2LL) at Johannesburg Hospital as part of a treatment plan for 39 cases of ovarian cancer from January 1981 to December 1986 after the cytoreductive surgery and chemotherapy were completed, with no clinically detectable tumor. Of these, 35 had cytoreductive surgery, and patients with stage II, III and IV were treated with cis-pla-tinum, doxorubicin and cyclophosphamide (CAP) combined with chemotherapy Most patients with stage I received a single treatment of alkylating agents. Various exams were performed before 2LL, including various tumor markers, EKG, chest X-ray, IVP, barium meal and ultrasound. 2LL Including: Collect abdominal punches for cytology